Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GLICK

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|March 1, 1989
Adjuvant therapy in node-negative breast cancer. A panel discussionW L McGuire, M D Abeloff, B Fisher, et al.
Cancer Genetics and Cytogenetics|September 1, 1987
Secondary Ph-positive CML with a minority monosomy 7 cloneH E Auerbach, T Stelmach, J G LaGuette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experienceJ M Bennett, K C Cain, J H Glick, et al.
Cancer|February 15, 1980
Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trialJ H Glick, R H Creech, S Torri, et al.
Cancer Treatment Reports|March 1, 1984
Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group studyF M Muggia, A A Tsiatis, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderlyS B Kahn, C B Begg, J J Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphomaE Z Ezdinli, J R Anderson, F Melvin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Phase I clinical trials of WR-2721 with alkylating agent chemotherapyJ H Glick, D J Glover, C Weiler, et al.
Breast Cancer Research and Treatment|January 1, 1981
Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancerJ H Glick, R H Creech, S Torri, et al.
JAMA|December 19, 1990
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic managementK A Schulman, B Kinosian, T A Jacobson, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|March 1, 1989
Adjuvant therapy in node-negative breast cancer. A panel discussionW L McGuire, M D Abeloff, B Fisher, et al.
Cancer Genetics and Cytogenetics|September 1, 1987
Secondary Ph-positive CML with a minority monosomy 7 cloneH E Auerbach, T Stelmach, J G LaGuette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experienceJ M Bennett, K C Cain, J H Glick, et al.
Cancer|February 15, 1980
Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trialJ H Glick, R H Creech, S Torri, et al.
Cancer Treatment Reports|March 1, 1984
Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group studyF M Muggia, A A Tsiatis, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderlyS B Kahn, C B Begg, J J Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphomaE Z Ezdinli, J R Anderson, F Melvin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Phase I clinical trials of WR-2721 with alkylating agent chemotherapyJ H Glick, D J Glover, C Weiler, et al.
Breast Cancer Research and Treatment|January 1, 1981
Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancerJ H Glick, R H Creech, S Torri, et al.
JAMA|December 19, 1990
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic managementK A Schulman, B Kinosian, T A Jacobson, et al.
Pageof 23